Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAID

Digestive and Liver Disease（2022）

引用 0|浏览11

暂无评分

摘要

Anti-TNF contraindications occurred in up to 11.5% of patients with Crohn's disease. Physicians' choices for alternative therapy to anti-TNF relied on ustekinumab in 75.6% and vedolizumab in 23.9% of these cases. This choice was driven mainly by phenotypical criteria and age.

查看译文

关键词

Anti-TNF,Contraindication,Crohn's disease,Inflammatory bowel disease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要